|
NR2C1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.372380E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.831780E-02 |
| Normal-vs-Stage2 |
8.898400E-02 |
| Normal-vs-Stage3 |
6.258000E-02 |
| Normal-vs-Stage4 |
2.307800E-02 |
| Stage1-vs-Stage2 |
8.642000E-01 |
| Stage1-vs-Stage3 |
8.399600E-01 |
| Stage1-vs-Stage4 |
5.233800E-01 |
| Stage2-vs-Stage3 |
9.943400E-01 |
| Stage2-vs-Stage4 |
7.735800E-01 |
| Stage3-vs-Stage4 |
7.482400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.001600E-03 |
| Normal-vs-AfricanAmerican |
1.375610E-01 |
| Normal-vs-Asian |
2.402600E-01 |
| Caucasian-vs-AfricanAmerican |
6.009200E-01 |
| Caucasian-vs-Asian |
1.198030E-01 |
| AfricanAmerican-vs-Asian |
1.437610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.161200E-03 |
| Normal-vs-Female |
1.079600E-01 |
| Male-vs-Female |
1.208180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.293600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.446200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.200300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.246000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.266160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.812000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.595200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.472000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.204400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.119200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.601400E-01 |
| Normal-vs-Grade 2 |
1.498440E-01 |
| Normal-vs-Grade 3 |
6.903700E-03 |
| Normal-vs-Grade 4 |
1.003980E-03 |
| Grade 1-vs-Grade 2 |
4.452200E-01 |
| Grade 1-vs-Grade 3 |
1.563640E-01 |
| Grade 1-vs-Grade 4 |
5.006500E-02 |
| Grade 2-vs-Grade 3 |
7.847800E-02 |
| Grade 2-vs-Grade 4 |
9.203000E-03 |
| Grade 3-vs-Grade 4 |
1.680820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.461700E-02 |
| Normal-vs-ccB subtype |
2.641800E-02 |
| ccA subtype-vs-ccB subtype |
2.706200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.464200E-02 |
| Normal-vs-N1 |
3.116400E-02 |
| N0-vs-N1 |
2.005000E-01 |
|
|
